Literature DB >> 23566268

Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.

Miguel Areia1, Rita Carvalho, Ana Teresa Cadime, Francisco Rocha Gonçalves, Mário Dinis-Ribeiro.   

Abstract

BACKGROUND: Cost-effectiveness studies are highly dependent on the models, settings, and variables used and should be based on systematic reviews. We systematically reviewed cost-effectiveness studies that address screening for gastric cancer and/or surveillance of precancerous conditions and lesions.
MATERIALS AND METHODS: A systematic review of cost-effectiveness studies was performed by conducting a sensitive search in seven databases (PubMed, Scopus, Web of Science, Current Contents Connect, Centre for Reviews and Dissemination, Academic Search Complete, and CINAHL Plus), independently evaluated by two investigators. Articles were evaluated for type of study, perspective, model, intervention, incremental cost-effectiveness ratio, clinical or cost variables, and quality, according to published guidelines.
RESULTS: From 2395 abstracts, 23 articles were included: 19 concerning population screening and 4 on following up premalignant lesions. Studies on Helicobacter pylori screening concluded that serology was cost-effective, depending on cancer incidence and endoscopy cost (incremental cost-effectiveness ratio: 6264-25,881), and eradication after endoscopic resection was also cost-effective (dominant) based on one study. Studies on imaging screening concluded that endoscopy was more cost-effective than no screening (incremental cost-effectiveness ratio: 3376-26,836). Articles on follow-up of premalignant lesions reported conflicting results (incremental cost-effectiveness ratio: 1868-72,519 for intestinal metaplasia; 18,600-39,800 for dysplasia). Quality assessment revealed a unanimous lack of a detailed systematic review and fulfillment of a median number of 23 items (20-26) of 35 possible ones.
CONCLUSIONS: The available evidence shows that Helicobacter pylori serology or endoscopic population screening is cost-effective, while endoscopic surveillance of premalignant gastric lesions presents conflicting results. Better implementation of published guidelines and accomplishment of systematic detailed reviews are needed.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Atrophic gastritis; Helicobacter pylori; Review; cost-effectiveness; costs and benefits; early detection of cancer; gastric cancer; gastric neoplasm; gastrointestinal endoscopy; intestinal metaplasia; stomach neoplasm

Mesh:

Year:  2013        PMID: 23566268     DOI: 10.1111/hel.12050

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  42 in total

Review 1.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

2.  Higher risk of gastric cancer among immigrants to Ontario: a population-based matched cohort study with over 2 million individuals.

Authors:  Rinku Sutradhar; Nnenna Asidianya; Faith Lee; Natalie Coburn; Linda Rabeneck; Lawrence Paszat
Journal:  Gastric Cancer       Date:  2017-12-28       Impact factor: 7.370

3.  Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Kun Yang; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Tumour Biol       Date:  2014-06-07

Review 4.  Implementation of gastric cancer screening - the global experience.

Authors:  Mārcis Leja; Weicheng You; M Constanza Camargo; Hiroshi Saito
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-09-28       Impact factor: 3.043

Review 5.  Biomarkers of Helicobacter pylori-associated gastric cancer.

Authors:  Cara L Cooke; Javier Torres; Jay V Solnick
Journal:  Gut Microbes       Date:  2013-07-12

Review 6.  [Precursors of gastric cancer : Dysplasia and adenoma].

Authors:  C Langner
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

Review 7.  Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed?

Authors:  Jin Young Park; David Forman; E Robert Greenberg; Rolando Herrero
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 8.  Endoscopic surveillance of gastrointestinal premalignant lesions: current knowledge and future directions.

Authors:  Veroushka Ballester; Marcia Cruz-Correa
Journal:  Curr Opin Gastroenterol       Date:  2014-09       Impact factor: 3.287

Review 9.  Helicobacter pylori: evidence-based review with a focus on immigrant populations.

Authors:  Derrick Siao; Ma Somsouk
Journal:  J Gen Intern Med       Date:  2013-09-25       Impact factor: 5.128

Review 10.  At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Authors:  Rahul S Dalal; Steven F Moss
Journal:  J Leukoc Biol       Date:  2014-05-13       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.